***Live: Wednesday, December 2, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET***Learn more about the recent trends in single-use sensors to match bioprocessing needs of bioreactor, fermenters, and mixing applications. Review data from 2-year studies of sensor testing.***On demand available after final airing until Dec. 2, 2021***
a capital investment project was required to replace the existing, obsolete high purity water (HPW) generation system and water-for-injection (WFI) generation system with new, reliable technology.
a capital investment project was required to replace the existing, obsolete high purity water (HPW) generation system and water-for-injection (WFI) generation system with new, reliable technology.
a capital investment project was required to replace the existing, obsolete high purity water (HPW) generation system and water-for-injection (WFI) generation system with new, reliable technology.
The author discusses the impact of prefilled syringe product contact materials and the filling and stoppering process on protein aggregates.
The authors provide an introduction to aluminum adsorbed vaccines, review studies of antigen stability, and propose test methods for the analysis of aluminum vaccine release and stability analysis.
Eurofins' BioPharma Product Testing offers complete CMC Testing Services for the bio/pharmaceutical industry.
The authors re-examine environmental controls in the context of technical advances in manufacturing.
Rinse sample analysis or visual inspection are risk-based approaches that can be correlated to surface cleanliness to replace surface sampling in a biopharmaceutical equipment cleaning process.
The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.
A case study evaluates the performance, control of operations, productivity, and cost savings of a single-use system.
Cell concentrations and resulting protein concentrations are higher in a concentrated fed-batch process than in a standard fed-batch culture system.
The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.
The authors examine the selection process of the contract manufacturing–pharmaceutical relationship and the communication challenges that pharmaceutical firms face prior to and during the CMO selection process.
The authors examine the selection process of the contract manufacturing–pharmaceutical relationship and the communication challenges that pharmaceutical firms face prior to and during the CMO selection process.
Contract manufacturers prepare for anticipated biosimilars manufacturing demands through expansion and acquisition.
Effective communication between contract manufacturing organizations and pharmaceutical company clients relies on well-defined master service and quality agreements.
This article reviews systems and processes that enable a laboratory to approach troubleshooting in an effective way, while also taking a proactive, preventive approach to managing atypical laboratory scenarios.
The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.
Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.
This article summarizes the approaches, challenges, and future perspectives for the characterization of N-glycans in biopharmaceutical products.
As more companies decouple drug substance from finished drug manufacturing operations, an integrated approach can ensure safe, reliable logistics for frozen storage and shipping.
As more companies decouple drug substance from finished drug manufacturing operations, an integrated approach can ensure safe, reliable logistics for frozen storage and shipping.
Production and process controls, organization and personnel were the top problems found, while packaging and labeling citations increased in 2017 and 2018.
How statistical methods and novel indices can be used to monitor and benchmark variability, to guide continuous improvement programs.
How statistical methods and novel indices can be used to monitor and benchmark variability, to guide continuous improvement programs.
New reports indicate that drug prices are slowing compared to other healthcare costs.
How statistical methods and novel indices can be used to monitor and benchmark variability, to guide continuous improvement programs.